With
Transfer Center and the African American Behavioral Health Center of Excellence
Presents a Special Training on:
Featured Presenter:
Gran Hovik, MA, Clinical Specialist, UCLA ISAP, Pacific Southwest Addiction Technology Transfer Center
|
|
Panelists:
David Hindman, Ph.D, Branch Chief, Sage EHR Management Branch, Interim Chief,
Clinical Standards & Training (CST) Unit, SAPC, LAC-DPH
Siddarth Puri, MD, Associate Medical Director of Prevention, SAPC, LAC-DPH
Lara Hoffman, LCSW, Director of SUD Services, Penny Lane Centers
William Taetzsch, LMFT, Program Director, Didi Hirsch
|
This lecture series presentation will describe the epidemiology of cannabis use in the United States. A brief overview of data on cannabis use in Los Angeles County will be presented. Cannabis pharmacology will be discussed, as well as its acute and chronic physical and psychological effects. Current research on how cannabis is used as a medical intervention and the legal questions that still surround medical cannabis despite its legalization in many states will be explored. Specific strategies that clinicians can utilize to communicate effectively with patients who are using cannabis for either medical or recreational purposes or who are considering its use will be presented. A panel discussion will follow this presentation featuring representatives from SAPC’s specialty provider network with particular experience or focus on Cannabis use and Cannabis Use Disorder in youth, adult and transitional age youth (TAY) patients as well as representative from SAPC’s Harm Reduction unit. |
Objectives: At the end of this presentation, participants will be able to:
1) Identify at least two (2) physical health and two (2) psychological health effects of cannabis use.
2) Explain at least three (3) reasons why individuals may use medical
cannabis.
3) Differentiate between at least three (3) effects associated with various cannabis routes of administration.
4) Recall at least two (2) racial/ethnic differences in cannabis use and treatment rates.
5) Discuss at least two (2) strategies for effectively communicating and working with patients who use cannabis for medicinal and/or recreational purposes receiving care within the Los Angeles County specialty SUD network.
The training course meets the qualifications for the provision of three (3.0) continuing education credits/ contact hours (CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for three (3.0) hours of continuing education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1123), CATCs (ACCBC/CAADE, #CP40 872 C 0822), and CAODCs (CADTP, #151).
CE credit will be awarded six-eight weeks after the virtual training. Partial credit will not be available for those participants who arrive late or leave early.
UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the
California Medical Association (CMA) through the joint providership of UCLA Integrated Substance Abuse Programs (ISAP) and SAPC. UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the CMA to provide continuing medical education for physicians.
UCLA Integrated Substance Abuse Programs (ISAP) designates this live virtual training course for a maximum of three (3.0) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal. Continuing medical education will be awarded within 6-8 weeks following completion of the training.
Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:
Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing (UCLA ISAP, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).
Please contact Brandy Oeser at 310-267-5331 or via email at [email protected] if you have questions or concerns.
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Brandy Oeser at (310) 267-5331 or via email at [email protected] by September 23, 2022.
This lecture series will be recorded.
Refund/Cancellation Policy: Notice of cancellation must be made at least 72 hours in advance of the training by emailing Brandy Oeser at [email protected]. You can also cancel directly via zoom.
Pre-registration is required and enrollment is limited to 1000 people. Registration will be accepted on a first come, first served basis.
You will receive a zoom confirmation if space has been reserved for you.
